2018•Unpublished venueRequires access

Human Papillomavirus (HPV) Vaccines

Aisha Hamdi Bushiha

Open publisher page 3 citations

Abstract

human papillomavirus which are a group of more than 200 related viruses. More than 40 types can be easily spread through direct sexual contact, other types of virus are responsible for non-genital warts, which are not sexually transmitted. HPV is the most common viral infection of the reproductive tract and is the cause of a range of conditions in both men and women, including precancerous lesions that may progress to cancer. Although the majority of HPV infections do not cause symptoms and resolve spontaneously, persistent infection with HPV may result in disease. In women, persistent infection with specific HPV types (most frequently HPV-16 and HPV-18) may lead to precancerous lesions which, if untreated, may progress to HPV infection is also associated with oropharyngeal and anogenital cancers and other (1) cervical cancer. conditions in men and women. HPV. HPV vaccination can reduce the risk of infection by the HPV types targeted by the vaccine. The Food and Drug Administration (FDA) has approved three vaccines to prevent HPV infection: Gardasil®, Gardasil® 9, and Cervarix®. These vaccines provide strong protection against new HPV infections, but they are not effective at treating established HPV infections or disease caused by HPV

About this research paper

What this paper is about

human papillomavirus which are a group of more than 200 related viruses. More than 40 types can be easily spread through direct sexual contact, other types of virus are responsible for non-genital warts, which are not sexually transmitted. HPV is the most common viral infection of the reproductive tract and is the cause of a range of conditions in both men and women, including precancerous lesions that may progress to cancer. Although the majority of HPV infections do not cause symptoms and resolve spontaneously, persistent infection with HPV may result in disease. In women, persistent infection with specific HPV types (most frequently HPV-16 and HPV-18) may lead to precancerous lesions which, if untreated, may progress to HPV infection is also associated with oropharyngeal and anogenital cancers and other (1) cervical cancer. conditions in men and women. HPV. HPV vaccination can reduce the risk of infection by the HPV types targeted by the vaccine. The Food and Drug Administration (FDA) has approved three vaccines to prevent HPV infection: Gardasil®, Gardasil® 9, and Cervarix®. These vaccines provide strong protection against new HPV infections, but they are not effective at treating established HPV infections or disease caused by HPV

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

human papillomavirus which are a group of more than 200 related viruses. More than 40 types can be easily spread through direct sexual contact, other types of virus are responsible for non-genital warts, which are not sexually transmitted. HPV is the most common viral infection of the reproductive tract and is the cause of a range of conditions in both men and women, including precancerous lesions that may progress to cancer. Although the majority of HPV infections do not cause symptoms and resolve spontaneously, persistent infection with HPV may result in disease. In women, persistent infection with specific HPV types (most frequently HPV-16 and HPV-18) may lead to precancerous lesions which, if untreated, may progress to HPV infection is also associated with oropharyngeal and anogenital cancers and other (1) cervical cancer. conditions in men and women. HPV. HPV vaccination can reduce the risk of infection by the HPV types targeted by the vaccine. The Food and Drug Administration (FDA) has approved three vaccines to prevent HPV infection: Gardasil®, Gardasil® 9, and Cervarix®. These vaccines provide strong protection against new HPV infections, but they are not effective at treating established HPV infections or disease caused by HPV

Key concepts: Gardasil, Medicine, Genital warts, HPV vaccines, HPV infection, Cervical cancer, Disease, Human papillomavirus

Related papers

Back to paper searchBrowse research topicsOriginal source
Human Papillomavirus (HPV) Vaccines — Research Paper | ScholarLens